author-photo

Alper Sevinc

University of Gaziantep
İnönü University

269

Papers

2397

Citations

Citation Trend

Filter By

Papers (171) Sort By

Journal Conference Others

Atherosclerotic Background of Cirrhosis in Sickle Cell Patients

2021 Middle East Journal of Nursing
Show All
- Source
- Cite
- Save
Citations (0)
2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

2020 BMJ Open
Show All
- Source
- Cite
- Save
Citations (0)
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.

2020
Show All
- Source
- Cite
- Save
Citations (0)
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

2019 Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

2018 OncoTargets and Therapy
Show All
- Source
- Cite
- Save
Citations (0)
P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)